On the public citation graph
Photothermal Therapy Improves the Efficacy of Topical Immunotherapy Against Melanoma
0 signed · 43 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/(sici)1097-0215(19990531)81:5<808::aid-ijc23>3.0.co;2-jopenalex-extracted
Long-term tumor resistance induced by laser photo-immunotherapy
inferredcites →https://doi.org/10.1002/(sici)1098-2388(199801/02)14:1<70::aid-ssu9>3.0.co;2-#openalex-extracted
Radiosurgery for the treatment of brain metastases
inferredcites →https://doi.org/10.1002/14651858.cd011123.pub2openalex-extracted
Systemic treatments for metastatic cutaneous melanoma
inferredcites →https://doi.org/10.1002/1878-0261.12851openalex-extracted
Targeting immunogenic cell death in cancer
inferredcites →https://doi.org/10.1002/ctm2.937openalex-extracted
Single‐cell RNA sequencing reveals localized tumour ablation and intratumoural immunostimulant delivery potentiate T cell mediated tumour killing
inferredcites →https://doi.org/10.1007/s00109-016-1415-2openalex-extracted
Primary melanoma tumor inhibits metastasis through alterations in systemic hemostasis
inferredcites →https://doi.org/10.1007/s12192-014-0523-6openalex-extracted
Upregulation of heat shock proteins and the promotion of damage-associated molecular pattern signals in a colorectal cancer model by modulated electrohyperthermia
inferredcites →https://doi.org/10.1016/j.bbcan.2020.188385openalex-extracted
Immunomodulatory effects of ablation therapy on tumors: Potentials for combination with immunotherapy
inferredcites →https://doi.org/10.1016/j.canlet.2008.05.026openalex-extracted
Hyperthermia on immune regulation: A temperature’s story
inferredcites →https://doi.org/10.1016/j.diii.2017.04.008openalex-extracted
Thermal ablation and immunomodulation: From preclinical experiments to clinical trials
inferredcites →https://doi.org/10.1016/j.hoc.2018.09.005openalex-extracted
Cutaneous Melanoma—A Review in Detection, Staging, and Management
inferredcites →https://doi.org/10.1016/j.smim.2016.01.001openalex-extracted
Combining targeted therapy with immunotherapy. Can 1+1 equal more than 2?
inferredcites →https://doi.org/10.1016/j.suc.2019.09.005openalex-extracted
Epidemiology and Risk Factors of Melanoma
inferredcites →https://doi.org/10.1016/s0304-3835(97)04707-1openalex-extracted
Laser-photosensitizer assisted immunotherapy: a novel modality for cancer treatment
inferredcites →https://doi.org/10.1038/nature21349openalex-extracted
Elements of cancer immunity and the cancer–immune set point
inferredcites →https://doi.org/10.1038/nrc3237openalex-extracted
Combining immunotherapy and targeted therapies in cancer treatment
inferredcites →https://doi.org/10.1039/c0pp00306aopenalex-extracted
Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients
inferredcites →https://doi.org/10.1056/nejme2116892openalex-extracted
A New Combination Immunotherapy in Advanced Melanoma
inferredcites →https://doi.org/10.1056/nejmra041245openalex-extracted
Management of Cutaneous Melanoma
inferredcites →https://doi.org/10.1080/02656736.2018.1446221openalex-extracted
Laser immunotherapy for cutaneous squamous cell carcinoma with optimal thermal effects to enhance tumour immunogenicity
inferredcites →https://doi.org/10.1093/bioinformatics/btp101openalex-extracted
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
inferredcites →https://doi.org/10.1093/jnci/djv381openalex-extracted
Stemming the Rising Incidence of Melanoma: Calling Prevention to Action
inferredcites →https://doi.org/10.1097/00008390-200102000-00009openalex-extracted
Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials
inferredcites →https://doi.org/10.1111/j.1365-2133.2005.06932.xopenalex-extracted
Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial
inferredcites →https://doi.org/10.1111/j.1365-2133.2006.07514.xopenalex-extracted
In situ photoimmunotherapy: a tumour-directed treatment for melanoma
inferredcites →https://doi.org/10.1155/2019/4508794openalex-extracted
Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response Rates
inferredcites →https://doi.org/10.1158/2326-6066.cir-17-0082openalex-extracted
Primary Tumors Limit Metastasis Formation through Induction of IL15-Mediated Cross-Talk between Patrolling Monocytes and NK Cells
inferredcites →https://doi.org/10.1186/s12916-016-0571-0openalex-extracted
Advances in immunotherapy for melanoma
inferredcites →https://doi.org/10.1186/s40425-019-0808-5openalex-extracted
Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition
inferredcites →https://doi.org/10.1258/0956462011924218openalex-extracted
Imiquimod 5% Cream is a Safe and Effective Self-Applied Treatment for Anogenital Warts — Results of an Open-Label, Multicentre Phase IIIB Trial
inferredcites →https://doi.org/10.1530/erc-17-0146openalex-extracted
The role of the tumour microenvironment in immunotherapy
inferredcites →https://doi.org/10.1590/s1807-59322009001000005openalex-extracted
Treatment of Cutaneous Tumors with Topical 5% Imiquimod Cream
inferredcites →https://doi.org/10.1634/theoncologist.2010-0190openalex-extracted
Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
inferredcites →https://doi.org/10.1634/theoncologist.2019-0438openalex-extracted
Intratumoral Immunotherapy—Update 2019
inferredcites →https://doi.org/10.2165/00003495-200666130-00001openalex-extracted
The Role of Topical Immune Response Modifiers in Skin Cancer
inferredcites →https://doi.org/10.3322/caac.21596openalex-extracted
A review of cancer immunotherapy toxicity
inferredcites →https://doi.org/10.3390/cancers13020210openalex-extracted
The Functional Crosstalk between Myeloid-Derived Suppressor Cells and Regulatory T Cells within the Immunosuppressive Tumor Microenvironment
inferredcites →https://doi.org/10.4065/82.4.490openalex-extracted
Malignant Melanoma in the 21st Century, Part 2: Staging, Prognosis, and Treatment
inferredcites →https://doi.org/10.4103/0253-7613.161249openalex-extracted
Imiquimod - Its role in the treatment of cutaneous malignancies
inferredcites →https://doi.org/10.4161/cbt.10.11.13434openalex-extracted
Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients
inferredcites →https://doi.org/10.7150/thno.65773openalex-extracted
Antigen presentation and interferon signatures in B cells driven by localized ablative cancer immunotherapy correlate with extended survival
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.